Literature DB >> 17344514

Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women.

Pamela J Mink1, Carolyn G Scrafford, Leila M Barraj, Lisa Harnack, Ching-Ping Hong, Jennifer A Nettleton, David R Jacobs.   

Abstract

BACKGROUND: Dietary flavonoids may have beneficial cardiovascular effects in human populations, but epidemiologic study results have not been conclusive.
OBJECTIVE: We used flavonoid food composition data from 3 recently available US Department of Agriculture databases to improve estimates of dietary flavonoid intake and to evaluate the association between flavonoid intake and cardiovascular disease (CVD) mortality.
DESIGN: Study participants were 34 489 postmenopausal women in the Iowa Women's Health Study who were free of CVD and had complete food-frequency questionnaire information at baseline. Intakes of total flavonoids and 7 subclasses were categorized into quintiles, and food sources were grouped into frequency categories. Proportional hazards rate ratios (RR) were computed for CVD, coronary heart disease (CHD), stroke, and total mortality after 16 y of follow-up.
RESULTS: After multivariate adjustment, significant inverse associations were observed between anthocyanidins and CHD, CVD, and total mortality [RR (95% CI) for any versus no intake: 0.88 (0.78, 0.99), 0.91 (0.83, 0.99), and 0.90 (0.86, 0.95)]; between flavanones and CHD [RR for highest quintile versus lowest: 0.78 (0.65, 0.94)]; and between flavones and total mortality [RR for highest quintile versus lowest: 0.88 (0.82, 0.96)]. No association was found between flavonoid intake and stroke mortality. Individual flavonoid-rich foods associated with significant mortality reduction included bran (added to foods; associated with stroke and CVD); apples or pears or both and red wine (associated with CHD and CVD); grapefruit (associated with CHD); strawberries (associated with CVD); and chocolate (associated with CVD).
CONCLUSION: Dietary intakes of flavanones, anthocyanidins, and certain foods rich in flavonoids were associated with reduced risk of death due to CHD, CVD, and all causes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17344514     DOI: 10.1093/ajcn/85.3.895

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  213 in total

Review 1.  Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease.

Authors:  V B Gencel; M M Benjamin; S N Bahou; R A Khalil
Journal:  Mini Rev Med Chem       Date:  2012-02       Impact factor: 3.862

2.  Protection by flavanol-rich foods against vascular dysfunction and oxidative damage: 27th Hohenheim Consensus Conference.

Authors:  Helmut Sies; Peter C H Hollman; Tilman Grune; Wilhelm Stahl; Hans K Biesalski; Gary Williamson
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

3.  Is bitter better? The benefits of chocolate for the cardiovascular system.

Authors:  H Evren Kaynak; Heinrich Taegtmeyer
Journal:  Curr Hypertens Rep       Date:  2011-12       Impact factor: 5.369

4.  Associations between dietary flavonoids and retinal microvasculature in older adults.

Authors:  Bamini Gopinath; Gerald Liew; Joshua R Lewis; Nicola P Bondonno; Catherine P Bondonno; George Burlutsky; Jonathan M Hodgson; Paul Mitchell
Journal:  Eur J Nutr       Date:  2019-11-25       Impact factor: 5.614

5.  Nutrigenomic analysis of the protective effects of bilberry anthocyanin-rich extract in apo E-deficient mice.

Authors:  Aurelie Mauray; Catherine Felgines; Christine Morand; Andrzej Mazur; Augustin Scalbert; Dragan Milenkovic
Journal:  Genes Nutr       Date:  2010-03-01       Impact factor: 5.523

6.  Tea and flavonoids: where we are, where to go next.

Authors:  Johanna T Dwyer; Julia Peterson
Journal:  Am J Clin Nutr       Date:  2013-10-30       Impact factor: 7.045

Review 7.  Grapes and cardiovascular disease.

Authors:  Mustali M Dohadwala; Joseph A Vita
Journal:  J Nutr       Date:  2009-07-22       Impact factor: 4.798

Review 8.  Flavonoids from fruit and vegetables: a focus on cardiovascular risk factors.

Authors:  J Y Toh; Verena M H Tan; Paul C Y Lim; S T Lim; Mary F F Chong
Journal:  Curr Atheroscler Rep       Date:  2013-12       Impact factor: 5.113

9.  Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells.

Authors:  Haitao Luo; Gary O Rankin; Lingzhi Liu; Matthew K Daddysman; Bing-Hua Jiang; Yi Charlie Chen
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

10.  Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc.

Authors:  Haitao Luo; Matthew K Daddysman; Gary O Rankin; Bing-Hua Jiang; Yi C Chen
Journal:  Cancer Cell Int       Date:  2010-05-11       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.